Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities researchers at Wedbush increased their Q2 2023 earnings per share (EPS) estimates for shares of Unity Biotechnology in a note issued to investors on Monday, May 15th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($0.70) per share for the quarter, up from […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities research analysts at Wedbush cut their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a research report issued to clients and investors on Tuesday, April 25th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($13.02) per share for the year, down […]
Several analysts have recently updated their ratings and price targets for Unity Biotechnology (NASDAQ: UBX): 3/28/2023 – Unity Biotechnology had its price target lowered by analysts at Wedbush from $35.00 to $5.00. They now have an “outperform” rating on the stock. 3/28/2023 – Unity Biotechnology had its “buy” rating reaffirmed by analysts at HC Wainwright. […]
Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price reduced by Wedbush from $35.00 to $5.00 in a report issued on Tuesday, The Fly reports. They currently have an outperform rating on the stock. Wedbush also issued estimates for Unity Biotechnology’s FY2026 earnings at ($12.94) EPS and FY2027 earnings at ($15.07) EPS. Several other […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Investment analysts at Wedbush decreased their FY2026 EPS estimates for Unity Biotechnology in a research note issued to investors on Tuesday, March 28th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($12.94) per share for the year, down from their prior estimate of ($12.04). […]